California is expecting an 88 percent drop in the number of Johnson & Johnson vaccines it will receive next week, according to The Mercury News. The state is expecting 67,600 next week compared to 572,700 doses this week, according to CDC data.
New Jersey also expects to see its Johnson & Johnson vaccine supply drop by about 88 percent, according to CDC data. The state expects to receive 15,600 Johnson & Johnson vaccine doses next week, compared to 131,600 this week. By the week of April 19, it expects to receive just 5,200 Johnson & Johnson vaccine doses, NJ Spotlight News reported.
Illinois expects 17,600 Johnson & Johnson vaccines doses to be delivered next week compared to 148,600 this week, also an 88 percent drop.
Shipments of the Johnson & Johnson vaccine to the federal government have slowed as the FDA investigates an error at an Emergent BioSolutions manufacturing plant in Baltimore that ruined about 15 million doses.
More articles on pharmacy:
Majority of people delaying their COVID-19 vaccination want J&J’s shot
Blood clots are a rare side effect of AstraZeneca’s COVID-19 vaccine, European Medicines Agency says
Emergent plant where 15M J&J vaccine doses ruined has history of failed quality audits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
